Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Stephanie Casey Parks, PhD
Cancer Pharmacology Leader at Independent
Speaker

Profile

Stephanie Casey Parks, Ph.D., is an oncology pharmacology leader with extensive experience in preclinical drug development. She most recently served as a Senior Principal Scientist and group leader at Amgen in Oncology Research. She has led in vivo research across diverse therapeutic modalities, including antibodies, antibody-drug conjugates, and T cell engagers. Her work has focused on characterizing emerging targets, evaluating pharmacodynamic and efficacy responses to novel therapeutics, and developing innovative preclinical models. She earned her B.S. from UCLA and Ph.D. in Cancer Biology from UC Irvine, followed by postdoctoral training at Stanford where she utilized mouse models to study oncogenes.

Agenda Sessions

  • Co-Chairs' Remarks: From Discovery to IND: What Matters Most and How to Get it Right

    , 1:00pm
  • Moderated Panel Discussion with Session Speakers

    , 4:15pm